263 related articles for article (PubMed ID: 26657153)
1. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.
Li L; Fang R; Liu B; Shi H; Wang Y; Zhang W; Zhang X; Ye L
Oncogene; 2016 Aug; 35(31):4048-57. PubMed ID: 26657153
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer.
Liu B; Wang T; Wang H; Zhang L; Xu F; Fang R; Li L; Cai X; Wu Y; Zhang W; Ye L
J Hematol Oncol; 2018 Feb; 11(1):26. PubMed ID: 29471853
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.
Liu F; You X; Wang Y; Liu Q; Liu Y; Zhang S; Chen L; Zhang X; Ye L
Carcinogenesis; 2014 May; 35(5):1144-53. PubMed ID: 24464787
[TBL] [Abstract][Full Text] [Related]
5. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
6. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
[TBL] [Abstract][Full Text] [Related]
7. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
Li L; Liu B; Zhang X; Ye L
Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
[TBL] [Abstract][Full Text] [Related]
9. The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation.
Hergovich A; Kohler RS; Schmitz D; Vichalkovski A; Cornils H; Hemmings BA
Curr Biol; 2009 Nov; 19(20):1692-702. PubMed ID: 19836237
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
[TBL] [Abstract][Full Text] [Related]
11. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
[TBL] [Abstract][Full Text] [Related]
12. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
[TBL] [Abstract][Full Text] [Related]
13. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.
Liu Q; Bai X; Li H; Zhang Y; Zhao Y; Zhang X; Ye L
Int J Cancer; 2013 Sep; 133(6):1310-22. PubMed ID: 23494474
[TBL] [Abstract][Full Text] [Related]
14. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
[TBL] [Abstract][Full Text] [Related]
15. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g.
Cai X; Wang X; Cao C; Gao Y; Zhang S; Yang Z; Liu Y; Zhang X; Zhang W; Ye L
Cancer Lett; 2018 Feb; 415():11-19. PubMed ID: 29174803
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.
Zhang Y; Zhao Y; Li L; Shen Y; Cai X; Zhang X; Ye L
Biochem Biophys Res Commun; 2013 May; 434(2):305-10. PubMed ID: 23537647
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.
Liu BW; Wang TJ; Li LL; Zhang L; Liu YX; Feng JY; Wu Y; Xu FF; Zhang QS; Bao MZ; Zhang WY; Ye LH
Acta Pharmacol Sin; 2019 Apr; 40(4):530-538. PubMed ID: 29925919
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
[TBL] [Abstract][Full Text] [Related]
19. The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells.
Xu F; You X; Liu F; Shen X; Yao Y; Ye L; Zhang X
Cancer Lett; 2013 Jun; 333(1):124-32. PubMed ID: 23352642
[TBL] [Abstract][Full Text] [Related]
20. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis.
Kim M; Kim M; Lee MS; Kim CH; Lim DS
Nat Commun; 2014 Nov; 5():5370. PubMed ID: 25367221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]